Improvement of the drug encapsulation into biodegradable polyester nanocarriers by blending of poly(lactic-co-glycolic acid) and polycaprolactone

Biocompatible and biodegradable polymers such as poly(lactic-co-glycolic acid), PLGA and polycaprolactone, PCL nanoparticles (NPs) have been used successfully as drug carriers in controlled drug release. The main weakness is the generally low drug loading (1–-5%) of the NPs. An option to enhance the...

Full description

Saved in:
Bibliographic Details
Main Authors: Ágnes Ábrahám, Gergő Gyulai, Tünde Tóth, Barna Szvoboda, Judith Mihály, Ákos Szabó, Éva Kiss
Format: Article
Language:English
Published: Budapest University of Technology and Economics 2022-09-01
Series:eXPRESS Polymer Letters
Subjects:
Online Access:http://www.expresspolymlett.com/letolt.php?file=EPL-0011932&mi=cd
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849700696183537664
author Ágnes Ábrahám
Gergő Gyulai
Tünde Tóth
Barna Szvoboda
Judith Mihály
Ákos Szabó
Éva Kiss
author_facet Ágnes Ábrahám
Gergő Gyulai
Tünde Tóth
Barna Szvoboda
Judith Mihály
Ákos Szabó
Éva Kiss
author_sort Ágnes Ábrahám
collection DOAJ
description Biocompatible and biodegradable polymers such as poly(lactic-co-glycolic acid), PLGA and polycaprolactone, PCL nanoparticles (NPs) have been used successfully as drug carriers in controlled drug release. The main weakness is the generally low drug loading (1–-5%) of the NPs. An option to enhance the drug content of NPs is to find the optimum matrix for a given drug molecule. To reveal the influence of matrix and drug polarity on the favoured encapsulation, polymeric NPs loaded with a series of alkyl-4-hydroxybenzoate (paraben) with increasing alkyl chain length (C1-C8) as model drugs were prepared by nanoprecipitation method. The paraben series represents the drugs with various polarities while the selected matrix polymers show increased hydrophobicity: PLGA with 50% lactic acid content (PLGA50) < PLGA with 75% lactic acid content (PLGA75) < PCL. The drug content of the PLGA NPs was found to significantly increase up to 10% with the hydrophobicity of the parabens, while encapsulation was further boosted by applying PCL. To find the proper fit between drug and matrix and finely tune the polarity of the NPs, as a novel approach, blends of PLGA50 and PCL were applied as matrix polymers. The drug loading of the NPs was proved to be dependent on the systematically changed blend composition. Furthermore, the introduction of PCL into the PLGA50 matrix improves the release kinetics of the active component.
format Article
id doaj-art-d838866198d74d82a9e8dfbb7d1c67c8
institution DOAJ
issn 1788-618X
language English
publishDate 2022-09-01
publisher Budapest University of Technology and Economics
record_format Article
series eXPRESS Polymer Letters
spelling doaj-art-d838866198d74d82a9e8dfbb7d1c67c82025-08-20T03:18:11ZengBudapest University of Technology and EconomicseXPRESS Polymer Letters1788-618X2022-09-0116996097710.3144/expresspolymlett.2022.70Improvement of the drug encapsulation into biodegradable polyester nanocarriers by blending of poly(lactic-co-glycolic acid) and polycaprolactoneÁgnes ÁbrahámGergő GyulaiTünde TóthBarna SzvobodaJudith MihályÁkos SzabóÉva KissBiocompatible and biodegradable polymers such as poly(lactic-co-glycolic acid), PLGA and polycaprolactone, PCL nanoparticles (NPs) have been used successfully as drug carriers in controlled drug release. The main weakness is the generally low drug loading (1–-5%) of the NPs. An option to enhance the drug content of NPs is to find the optimum matrix for a given drug molecule. To reveal the influence of matrix and drug polarity on the favoured encapsulation, polymeric NPs loaded with a series of alkyl-4-hydroxybenzoate (paraben) with increasing alkyl chain length (C1-C8) as model drugs were prepared by nanoprecipitation method. The paraben series represents the drugs with various polarities while the selected matrix polymers show increased hydrophobicity: PLGA with 50% lactic acid content (PLGA50) < PLGA with 75% lactic acid content (PLGA75) < PCL. The drug content of the PLGA NPs was found to significantly increase up to 10% with the hydrophobicity of the parabens, while encapsulation was further boosted by applying PCL. To find the proper fit between drug and matrix and finely tune the polarity of the NPs, as a novel approach, blends of PLGA50 and PCL were applied as matrix polymers. The drug loading of the NPs was proved to be dependent on the systematically changed blend composition. Furthermore, the introduction of PCL into the PLGA50 matrix improves the release kinetics of the active component.http://www.expresspolymlett.com/letolt.php?file=EPL-0011932&mi=cdbiocompatible polymerscontrolled drug deliverypolycaprolactonepoly(lactic-co-glycolic acid)blended polymeric nanoparticles
spellingShingle Ágnes Ábrahám
Gergő Gyulai
Tünde Tóth
Barna Szvoboda
Judith Mihály
Ákos Szabó
Éva Kiss
Improvement of the drug encapsulation into biodegradable polyester nanocarriers by blending of poly(lactic-co-glycolic acid) and polycaprolactone
eXPRESS Polymer Letters
biocompatible polymers
controlled drug delivery
polycaprolactone
poly(lactic-co-glycolic acid)
blended polymeric nanoparticles
title Improvement of the drug encapsulation into biodegradable polyester nanocarriers by blending of poly(lactic-co-glycolic acid) and polycaprolactone
title_full Improvement of the drug encapsulation into biodegradable polyester nanocarriers by blending of poly(lactic-co-glycolic acid) and polycaprolactone
title_fullStr Improvement of the drug encapsulation into biodegradable polyester nanocarriers by blending of poly(lactic-co-glycolic acid) and polycaprolactone
title_full_unstemmed Improvement of the drug encapsulation into biodegradable polyester nanocarriers by blending of poly(lactic-co-glycolic acid) and polycaprolactone
title_short Improvement of the drug encapsulation into biodegradable polyester nanocarriers by blending of poly(lactic-co-glycolic acid) and polycaprolactone
title_sort improvement of the drug encapsulation into biodegradable polyester nanocarriers by blending of poly lactic co glycolic acid and polycaprolactone
topic biocompatible polymers
controlled drug delivery
polycaprolactone
poly(lactic-co-glycolic acid)
blended polymeric nanoparticles
url http://www.expresspolymlett.com/letolt.php?file=EPL-0011932&mi=cd
work_keys_str_mv AT agnesabraham improvementofthedrugencapsulationintobiodegradablepolyesternanocarriersbyblendingofpolylacticcoglycolicacidandpolycaprolactone
AT gergogyulai improvementofthedrugencapsulationintobiodegradablepolyesternanocarriersbyblendingofpolylacticcoglycolicacidandpolycaprolactone
AT tundetoth improvementofthedrugencapsulationintobiodegradablepolyesternanocarriersbyblendingofpolylacticcoglycolicacidandpolycaprolactone
AT barnaszvoboda improvementofthedrugencapsulationintobiodegradablepolyesternanocarriersbyblendingofpolylacticcoglycolicacidandpolycaprolactone
AT judithmihaly improvementofthedrugencapsulationintobiodegradablepolyesternanocarriersbyblendingofpolylacticcoglycolicacidandpolycaprolactone
AT akosszabo improvementofthedrugencapsulationintobiodegradablepolyesternanocarriersbyblendingofpolylacticcoglycolicacidandpolycaprolactone
AT evakiss improvementofthedrugencapsulationintobiodegradablepolyesternanocarriersbyblendingofpolylacticcoglycolicacidandpolycaprolactone